Monitor the May 12 earnings release and call for updates on revenue, EPS, and guidance. This filing itself contains no new financial information.
RDY drugs
RDY drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 24 $13.67entry
- T+1 · 7mo ago +2.19%α +2.03% · $13.97
- T+5 · 7mo ago −0.22%α −1.13% · $13.64
- T+20 · 6mo ago −0.88%α −4.90% · $13.55
- T+60 · 4mo ago −8.12%α −13.20% · $12.56
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Dr. Reddy's Laboratories announced it will release its Q4 and full year FY26 results on May 12, 2026, followed by an earnings call. This 6-K filing serves to notify exchanges and investors of the upcoming event.
Key Facts
- Company will release Q4 and full year FY26 financial results on May 12, 2026, after the board meeting.
- Earnings call scheduled for 19:30 IST (10:00 AM ET) on the same day.
- Filing is a standard notification under Form 6-K, not the actual financial results.
Financial Impact
No financial data disclosed in this filing, only an announcement of future results release.
Risk Factors
- Market may react negatively if actual results on May 12 fall short of expectations.
- Guidance provided during the call could influence near-term stock price movement.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000263 |
| Document: 0001575872-26-000263-index.html | 0001575872-26-000263 |
| Document: 0001575872-26-000263.txt | 0001575872-26-000263 |
Track record
73 reports on RDY
7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
- Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
- Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
- Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
- Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers